Page last updated: 2024-08-17

quinoxalines and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

quinoxalines has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's14 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damilano, F; Emanueli, C; Hirsch, E; Katare, R; Madeddu, P; Meloni, M; Siragusa, M1
Minna, JD; Petersen, SL; Peyton, M; Wang, X1
Castillo, C; Castillo, EF; López, RM; Pérez, T1
Buontempo, F; Capitani, S; Cetin-Atalay, R; Ersahin, T; Etro, D; Missiroli, S; Neri, ML; Ozturk, M; Senturk, S1
Carlotti, A; Douguet, L; Dupin, N; Dwyer, J; Galan Moya, EM; Gavard, J; Grange, PA; Gutkind, JS; Le Guelte, A; Sumbal, M1
Barbero, A; Benvenuto, F; Bocelli-Tyndall, C; Di Maggio, N; Iezzi, G; Martin, I; Pistoia, V; Schaeren, S; Scherberich, A; Spagnoli, G; Trella, E; Tyndall, A; Vukcevic, M; Zajac, P1
Ahn, SJ; Backx, PH; Baek, J; Bradley, CA; Choi, JH; Choi, SY; Collingridge, GL; Jang, DJ; Kaang, BK; Kim, E; Kim, H; Kim, JI; Kim, KH; Kim, SJ; Ko, HG; Kwak, C; Lee, HR; Lee, K; Lee, YS; Park, SW; Sim, SE; Yu, NK; Zhuo, M1
Bai, SZ; Guo, J; He, W; Kong, FJ; Li, GW; Li, HX; Li, HZ; Tian, Y; Wang, R; Wu, LY; Xi, YH; Xing, WJ; Xu, CQ; Yang, GD1
Dorigo, O; Eng, C; Fekete, M; Santiskulvong, C1
Jhiang, SM; Liu, YY; Ringel, MD; Zhang, X1
Donaldson, DS; Gally, DL; Gillespie, TL; Haas, J; Lengeling, A; Mabbott, NA; Mahajan, A; Mahajan, S; Malterer, G; O'Shea, M; Paxton, E; Roe, AJ; Shaw, DJ; Tahoun, A; Tan, A; Wang, D1
Dayan, CM; Draman, MS; Grennan-Jones, F; Lane, C; Ludgate, M; Morris, D; Tee, AR; Zhang, L1
Araki, N; Hayashida, Y; Ikeda, Y; Kakehi, Y; Kato, T; Kawai, K; Sawada, K1
Fan, TT; Feng, XY; Gao, F; Liu, Q; Yang, YZ1

Other Studies

14 other study(ies) available for quinoxalines and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

ArticleYear
Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice.
    Circulation research, 2010, Mar-05, Volume: 106, Issue:4

    Topics: Animals; Apoptosis; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Chromones; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inflammation; Leukocytes; Male; Mice; Morpholines; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Recovery of Function; Regeneration; RNA Interference; Signal Transduction; Thiazolidinediones; Time Factors; Transfection; Ventricular Function, Left

2010
Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Jun-29, Volume: 107, Issue:26

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Baculoviral IAP Repeat-Containing 3 Protein; Base Sequence; Biomimetic Materials; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chromones; Drug Resistance, Neoplasm; Humans; I-kappa B Kinase; Imidazoles; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Mitochondrial Proteins; Morpholines; NF-kappa B; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Receptor-Interacting Protein Serine-Threonine Kinases; RNA, Small Interfering; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Up-Regulation

2010
Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: a comparative study.
    Fundamental & clinical pharmacology, 2011, Volume: 25, Issue:3

    Topics: Androstadienes; Angiotensin II; Animals; Aorta, Thoracic; Chromones; Endothelium, Vascular; Guanylate Cyclase; Isometric Contraction; Male; Morpholines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxadiazoles; Phenylephrine; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Potassium; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Wortmannin

2011
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status.
    Investigational new drugs, 2011, Volume: 29, Issue:6

    Topics: Androstadienes; Antineoplastic Agents; Apoptosis; Benzimidazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromones; Humans; Inhibitory Concentration 50; Liver Neoplasms; Morpholines; Proto-Oncogene Proteins c-akt; Quinoxalines; Signal Transduction; Wortmannin

2011
Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor.
    Oncogene, 2011, Jan-13, Volume: 30, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Androstadienes; Animals; Antigens, CD; Cadherins; Capillary Permeability; Cell Line; Chromones; Cinnamates; Endothelial Cells; Enzyme Inhibitors; Female; Furans; Herpesvirus 8, Human; Humans; Indoles; Intercellular Junctions; Mice; Mice, Nude; Morpholines; Phosphatidylinositol 3-Kinases; Pyridines; Pyrimidines; Quinoxalines; Receptors, Chemokine; RNA, Small Interfering; Sarcoma, Kaposi; Skin; Skin Neoplasms; Sulfonamides; Thiazolidinediones; Wortmannin

2011
Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells.
    Arthritis and rheumatism, 2010, Volume: 62, Issue:12

    Topics: Cell Proliferation; Cells, Cultured; Chromones; Fibroblast Growth Factor 2; Flavonoids; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Interferon-gamma; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinase Kinases; Morpholines; Nuclear Proteins; Phosphoinositide-3 Kinase Inhibitors; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-akt; Quinoxalines; Thiazolidinediones; Trans-Activators

2010
PI3Kγ is required for NMDA receptor-dependent long-term depression and behavioral flexibility.
    Nature neuroscience, 2011, Oct-23, Volume: 14, Issue:11

    Topics: Analysis of Variance; Animals; Behavior, Animal; Biophysics; Chromones; Class Ib Phosphatidylinositol 3-Kinase; Conditioning, Classical; Electric Stimulation; Environment; Enzyme Inhibitors; Excitatory Amino Acid Agents; Excitatory Postsynaptic Potentials; Exploratory Behavior; Extinction, Psychological; Fear; Female; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; In Vitro Techniques; Long-Term Synaptic Depression; Male; Maze Learning; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Neurons; Oncogene Protein v-akt; Phosphorylation; Quinoxalines; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Signal Transduction; Thiazolidinediones; Time Factors

2011
Involvement of calcium-sensing receptor in oxLDL-induced MMP-2 production in vascular smooth muscle cells via PI3K/Akt pathway.
    Molecular and cellular biochemistry, 2012, Volume: 362, Issue:1-2

    Topics: Adamantane; Animals; Anthracenes; Aorta; Atherosclerosis; Cells, Cultured; Chromones; Gadolinium; JNK Mitogen-Activated Protein Kinases; Lipoproteins, LDL; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Morpholines; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing

2012
Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells.
    Anticancer research, 2012, Volume: 32, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cell Line, Tumor; Chromones; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Gemcitabine; Humans; Morpholines; Ovarian Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Signal Transduction; Topotecan

2012
Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.
    Endocrine-related cancer, 2012, Volume: 19, Issue:3

    Topics: Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Chromones; Enzyme Inhibitors; Flavonoids; HEK293 Cells; Humans; Iodine Radioisotopes; Mechanistic Target of Rapamycin Complex 1; Morpholines; Multiprotein Complexes; Phosphoinositide-3 Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; RNA, Messenger; Sirolimus; Symporters; Thyroid Gland; Thyrotropin; TOR Serine-Threonine Kinases

2012
Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion.
    Cell host & microbe, 2012, Nov-15, Volume: 12, Issue:5

    Topics: Aminophenols; Animals; Bacterial Proteins; Benzylamines; beta Catenin; Cell Differentiation; Cell Transdifferentiation; Cells, Cultured; Chromones; Enterocytes; Epithelial Cells; Epithelial-Mesenchymal Transition; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Intestinal Mucosa; Maleimides; Mice; Mice, Inbred C57BL; Morpholines; NF-kappa B; Peptides; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Salmonella Infections; Salmonella typhimurium; Snail Family Transcription Factors; Transcription Factor RelB; Transcription Factors; Vimentin; Wnt Proteins; Wnt Signaling Pathway

2012
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:7

    Topics: Adipogenesis; Cells, Cultured; Chromones; Drug Discovery; Gene Expression Regulation; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Molecular Targeted Therapy; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinoxalines; Receptor, IGF Type 1; Receptors, Thyrotropin; Signal Transduction; Thiazolidinediones

2014
Invention of a novel photodynamic therapy for tumors using a photosensitizing PI3K inhibitor.
    International journal of cancer, 2016, 08-01, Volume: 139, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chromones; Dose-Response Relationship, Drug; Humans; Light; Macrophages; Mice; Molecular Imaging; Morpholines; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Photochemotherapy; Photosensitizing Agents; Quinoxalines; Reactive Oxygen Species; Sulfonamides

2016
Downregulation of PI3K-γ in a mouse model of sepsis-induced myocardial dysfunction.
    Cytokine, 2017, Volume: 96

    Topics: Animals; Cardiomyopathies; Chromones; Class II Phosphatidylinositol 3-Kinases; Cytokines; Disease Models, Animal; Down-Regulation; Interleukin-6; Lipopolysaccharides; Mice; Morpholines; Myocardium; Quinoxalines; Sepsis; Signal Transduction; Thiazolidinediones; Tumor Necrosis Factor-alpha

2017